Table 2

Comparison of the clinical outcomes between the two groups

EUS-GBD
n=39
PT-GBD
n=40
P value
1-year adverse events (%)10 (25.6)31 (77.5)<0.001
 Grading 1/2/3/4/51/1/6/0/213/6/8/0/4
 Recurrent acute cholecystitis (%)1 (2.6)8 (20)0.029
Reinterventions after 30 days (%)1 (2.6)12 (30)0.001
 Reinsertion of PT-GBD012
 Clearing blocked stent10
Unplanned admissions (%)6 (15.4)20 (50)0.002
30-day adverse events (%)5 (12.8)19 (47.5)0.001
 Grading 1/2/3/4/50/1/2/0/26/4/5/0/4
30-day mortality (%)3 (7.7)4 (10)1
Technical success (%)38 (97.4)40 (100)0.494
Clinical success (%)36 (92.3)37 (92.5)1
Procedure time (minutes)22.7 (13.0)27.4 (12.0)0.108
Analgesic requirements
(total paracetamol in mg)
3345 (5663)5165 (5068)0.034
Hospital stay (days)*8 (4–13)9 (7–14)0.181
  • Values are shown in mean (SD) unless otherwise specified.

  • *Values shown in median (IQR).